- Home
- CNTA vs FOUR Comparison
CNTA vs FOUR Comparison
Compare CNTA & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | FOUR |
|---|---|---|
| Founded | 2020 | 1999 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CNTA | FOUR |
|---|---|---|
| Price | $25.11 | $59.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 23 |
| Target Price | $38.50 | ★ $95.87 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,330,600,000.00 |
| Revenue This Year | N/A | $28.63 |
| Revenue Next Year | N/A | $24.46 |
| P/E Ratio | ★ N/A | $27.53 |
| Revenue Growth | N/A | ★ 29.86 |
| 52 Week Low | $9.60 | $52.65 |
| 52 Week High | $30.58 | $107.16 |
Technical Indicators
Market Signals| Indicator | CNTA | FOUR |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 47.89 |
| Support Level | $22.50 | $53.88 |
| Resistance Level | $25.80 | $61.63 |
| Average True Range (ATR) | 1.29 | 2.72 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 63.34 | 74.91 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About FOUR Shift4 Payments Inc.
Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.